Insider filing · DNTH
Simrat Randhawa
EVP, Head of R&D
profile →
Dianthus Therapeutics, Inc.
DNTH · Healthcare · 18 filings in 24 months
ticker →
Simrat Randhawa sold $7.4M of Dianthus Therapeutics (DNTH)
Executed Nov 13 2025, disclosed Nov 14 2025, 1 day later.
Value, as filed
$7.4M
196,538 sh across 4 lots
Executed
Nov 13 2025
the trade date, as filed
Disclosed
Nov 14 2025
1 day after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
SRSimrat Randhawa (EVP, Head of R&D) filed 4 Form 4 reports in the trailing twelve months (0 purchases, 4 sales), most often in Dianthus Therapeutics, Inc. (DNTH). The largest single filing was $7.4M of DNTH (196,538 sh across 4 lots, as filed), executed Nov 13 2025.
The name
DNTHHealthcare · Dianthus Therapeutics, Inc., a clinical-stage biotechnology company, engages in the development of therapies for patients with severe autoi…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Simrat Randhawa in DNTH
DNTHSALE
Dianthus Therapeutics, Inc.
$2.5M23,124 sh across 3 lots
Exec Sep 1
Filed Sep 3 · 4:30 PM ET DNTHSALE Dianthus Therapeutics, Inc. $2.4M
26,530 sh across 3 lots
Exec Jun 1
Filed Jun 2 · 5:30 PM ET DNTHSALE Dianthus Therapeutics, Inc. $2.8M
33,830 sh × $81.48
Exec Mar 12
Filed Mar 13 · 5:30 PM ET